Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2020 | FLIPPER trial: an update

Joan Albanell, MD, Pompeu Fabra University, Barcelona, Spain, discusses the results from the FLIPPER trial (NCT02690480). The FLIPPER trial is a randomized Phase II study that investigated the efficacy of fulvestrant plus palbociclib vs fulvestrant plus placebo in postmenopausal women with hormone receptor positive (HR+)/HER2 negative (HER2–) endocrine-sensitive advanced breast cancer (ABC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.